The authors detected a median of 38 predicted neoantigens per tumor, and showed that the association of higher neoantigen quantity and CD8+ T-cell infiltrate with survival was independent of adjuvant chemotherapy, suggesting that neoantigen quality, and not purely quantity, correlates with survival (54). Here, CD8A is linked to neoplasm.